Eagleslanding Diabetes & Endocrinology
550 Eagleslanding Parkway, Suite 110, Stockbridge, GA 30281. EIN 30-0084490. Self-funded (stop-loss)Plan year 2024
Health care & social assistance (NAICS 621111)
Eagleslanding Diabetes & Endocrinology (Stockbridge, GA, 12 participants) has a self-funded health plan with stop-loss from NFA Health Plus Incorporated Cell. Coverage renews in May.
- Participants
- 12
- Funding
- Self-funded (stop-loss)
- Renews
- May
- Premium
- $75,340
- Comp rate
- 0.0%
- Broker of record
- None on Schedule A
- Carriers by line
- Plan year
- 2024
- Source
- Form 5500, filed 2026
Schedule A contracts, plan year 2024
| Lines | Carrier | Policy year | Covered | Premium | Per covered / mo | Broker comp | Comp rate | Paid to |
|---|---|---|---|---|---|---|---|---|
| Stop-Loss, Dental, Medical | NFA Health Plus Incorporated Cell | May 1, 2024 to Apr 30, 2025 |
12 | $75,340 | $523 median $413 |
$0 | 0.0% | None listed |
Source: Form 5500, Schedule A. Commissions and fees as reported. Per covered / mo = premium ÷ covered lives ÷ 12, with the median for the same line and group size.
Premium by plan year
Brokers
No broker is paid on Schedule A.
Other service providers
| Provider | Service | Fees |
|---|
Schedule C: providers paid $5,000 or more by the plan, mostly on large and self-funded plans. Roles come from the filing's service codes.
Plan-year history, 2021–2024
| Plan year | Participants | Premium | Broker comp | Medical funding | Top carriers | Brokers |
|---|---|---|---|---|---|---|
| 2024 | 12 | $75K | $0 | Self-funded (stop-loss) | NFA Health Plus Incorporated Cell | None listed |
| 2023 | 5 | $33K | $0 | Self-funded (stop-loss) | NFA Health Plus Incorporated Cell | None listed |
| 2022 | 7 | $29K | $0 | Self-funded (stop-loss) | NFA Health Plus Incorporated Cell | None listed |
| 2021 | 6 | $28K | $0 | Self-funded (stop-loss) | NFA Health Plus Incorporated Cell | None listed |
Across all of this employer's welfare plans, as filed. Years with missing or partial filings show smaller totals.
Plans
| Plan | Type | Funding | Participants | Filing |
|---|---|---|---|---|
| Employee Health Plan of Eagleslanding Diabetes & Endocrinology (plan 501) Plan year May 1, 2024 – Apr 30, 2025 · received Feb 4, 2026 | Health, Dental | Insurance + Trust | 12 | Filing PDF |
What this page can't tell you: Schedule A reports insurance contracts, not enrollment by plan, and self-funded claims don't appear on it. Plans under 100 participants often don't file. Data as filed with the U.S. Department of Labor through Oct 24, 2026. Something wrong? Report a data issue.